Released Apr 29, 2015, after the close
10-K filed Apr 29, 2015, 119 days after period end · 0001564590-15-003012
Q4 2014 · 10-K
Revenue$100.28M$100.28M −5.3% vs Q4 2013−0.7% vs Q3 2014
Net Income-$5.80M-$5.80M N/M vs Q4 2013N/M vs Q3 2014
EPS Diluted-$0.31-$0.31 N/M vs Q4 2013N/M vs Q3 2014
Gross Profit$78,827,000+9.8%
Operating Income$3,953,000N/M
Operating Cash Flowderived$15,198,000+0.4%
Free Cash Flowderived$8,453,000−13.6%
Margins · derived
Gross margin78.6%+10.8 pt vs Q4 2013
Operating margin3.9%+13.5 pt vs Q4 2013
Net margin-5.8%+4.1 pt vs Q4 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Revenue | $100.28M | $105.89M | $115.61M | $118.64M |
| Net Income | -$5.80M | -$10.41M | $22.95M | $7.89M |
| EPS Diluted | -$0.31 | -$0.58 | $1.17 | $0.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR